Publikationen von Florian Holsboer

Maccarrone, G.; Birg, I.; Malisch, E.; Rosenhagen, M. C.; Ditzen, C.; Chakel, J. A.; Mandel, F.; Reimann, A.; Doertbudak, C.-C.; Haegler, K. et al.; Holsboer, F.; Turck, C. W.: In-depth analyis of the human CSF proteome using protein prefractionation. Clinical Proteomics Journal 1 (3-4), S. 333 - 364 (2004)

Majer, M.; Ising, M.; Künzel, H.; Binder, E. B.; Holsboer, F.; Modell, S.; Zihl, J.: Impaired divided attention predicts delayed response and risk to relapse in subjects with depressive disorders. Psychological Medicine 34, S. 1453 - 1463 (2004)

Müller, M. B.; Uhr, M.; Holsboer, F.; Keck, M. E.: Hypothalamic-pituitary-adrenocortical system and mood disorders: Highlights from mutant mice. Neuroendocrinology 79 (1), S. 1 - 12 (2004)

Murck, H.; Held, K.; Ziegenbein, M.; Künzel, H.; Holsboer, F.; Steiger, A.: Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29, S. 1205 - 1211 (2004)

Oertel, H.; Schneider, H. J.; Stalla, G. K.; Holsboer, F.; Zihl, J.: The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism. Psychoneuroendocrinology 29, S. 839 - 850 (2004)

Post, A.; Almeida, O. F. X.; Holsboer, F.: Signal Pathways Mediating Antidepressant and Antipsychotic Drugs on Neuronal Cell Survival. Current Medicinal Chemistry. - Central Nervous System Agents 4, S. 105 - 118 (2004)

Rammes, G.; Eisensamer, B.; Ferrari, U.; Shapa, M.; Gimpl, G.; Gilling, K.; Parsons, C.; Riering, K.; Hapfelmeier, G.; Bondy, B. et al.; Zieglgänsberger, W.; Holsboer, F.; Rupprecht, R.: Antipsychotic drugs antagonize human serotonin type 3 (5-HT₃) receptor currents in a noncompetitive manner [Image]. Molecular Psychiatry 9 (9), S. 818 - 818 (2004)

Rüegg, J.; Holsboer, F.; Turck, C.; Rein, T.: Cofilin 1 is revealed as an inhibitor of glucocorticoid receptor by analysis of hormone-resistant cells. Molecular and Cellular Biology 24 (21), S. 9371 - 9382 (2004)

Storch, C.; Höhne, A.; Holsboer, F.; Ohl, F.: Activity patterns as a correlate for sleep-wake behaviour in mice. Journal of Neuroscience Methods 133, S. 173 - 179 (2004)

Wigger, A.; Sánchez, M. M.; Mathys, K. C.; Ebner, K.; Frank, E.; Liu, D.; Kresse, A.; Neumann, I. D.; Holsboer, F.; Plotsky, P. M. et al.; Landgraf, R.: Alterations in central neuropeptide expression, release, and receptor binding in rats bred for high anxiety: critical role of vasopressin. Neuropsychopharmacology 29, S. 1 - 14 (2004)

Künzel, H. E.; Binder, E. B.; Nickel, T.; Ising, M.; Fuchs, B.; Majer, M.; Pfennig, A.; Ernst, G.; Kern, N.; Schmid, D. A. et al.; Uhr, M.; Holsboer, F.; Modell, S.: Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28 (12), S. 2169 - 2178 (2003)

Künzel, H. E.; Zobel, A. W.; Nickel, T.; Ackl, N.; Uhr, M.; Sonntag, A.; Ising, M.; Holsboer, F.: Treatment of depression with the CRH-1-receptor antagonist R121919: endocrine changes and side effects. Journal of Psychiatric Research 37 (6), S. 525 - 533 (2003)

Adena, S. M.; Ising, M.; Lauer, C.; Holsboer, F.; Modell, S.: The effects of RS-86 on sleep with respect to depression and HLA-type. Pharmacopsychiatry 36 (5), S. 210 - 210 (2003)

Brunner, J.; Ising, M.; Binder, E. B.; Künzel, H. E.; Nickel, T.; Pfennig, A.; Kern, N.; Fuchs, B.; Majer, M.; Holsboer, F. et al.; Modell, S.: Prediction of response to antidepressant monotherapy. Pharmacopsychiatry 36 (5), S. 216 - 216 (2003)

Czisch, M.; Wehrle, R.; Kaufmann, C.; Wetter, T. C.; Holsboer, F.; Pollmächer, T.; Auer, D. P.: Thalamo-cortical synchronization across the sleep-wake cycle: A combined fMRI/EEG study. Pharmacopsychiatry 36 (5), S. 218 - 218 (2003)

Deussing, J.; Breu, J.; Binder, E. B.; Ohl, F.; Holsboer, F.; Wurst, W.: Addressing in vivo functions of urocortin III, a novel member of the CRH family of neuropeptides. Pharmacopsychiatry 36 (5), S. 221 - 221 (2003)

Eisensamer, B.; Rammes, G.; Gimpl, G.; Shapa, M.; Ferrari, U.; Hapfelmeier, G.; Bondy, B.; Parsons, C.; Gilling, K.; Zieglgänsberger, W. et al.; Holsboer, F.; Rupprecht, R.: Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Pharmacopsychiatry 36 (5), S. 223 - 223 (2003)

Herr, A. S.; Tsolakidou, A.; Yassouridis, A.; Holsboer, F.; Rein, T.: Antidepressants differentially influence the transcriptional activity of the glucocorticoid receptor in vitro. Pharmacopsychiatry 36 (5), S. 233 - 233 (2003)

Ising, M.; Adena, S. M.; Pfennig, A.; Binder, E. B.; Kern, N.; Huber, J.; Modell, S.; Holsboer, F.: Munich Vulnerability Study - Familial vulnerability for affective disorders: Search for endophenotypes. Pharmacopsychiatry 36 (5), S. 237 - 237 (2003)

Ising, M.; Binder, E.; Brunner, J.; Fuchs, B.; Kern, N.; Künzel, H. E.; Majer, M.; Nickel, T.; Pfennig, A.; Modell, S. et al.; Holsboer, F.: Subsyndromal AMDP scales to distinguish pathogenetically homogenous subgroups of affective disorders. Pharmacopsychiatry 36 (5), S. 237 - 237 (2003)